149.93 USD
-1.52 (-1%)
Last: Feb 3, 2026, 01:23 PM
ICUI gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 186 industry peers in the Health Care Equipment & Supplies industry. ICUI has an average financial health and profitability rating. ICUI has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
- ICUI had positive earnings in the past year.
- In the past year ICUI had a positive cash flow from operations.
- The reported net income has been mixed in the past 5 years: ICUI reported negative net income in multiple years.
- ICUI had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of -0.18%, ICUI is in the better half of the industry, outperforming 73.12% of the companies in the same industry.
- With a decent Return On Equity value of -0.35%, ICUI is doing good in the industry, outperforming 73.66% of the companies in the same industry.
- ICUI has a better Return On Invested Capital (2.86%) than 70.43% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for ICUI is significantly below the industry average of 8.80%.
- The last Return On Invested Capital (2.86%) for ICUI is above the 3 year average (1.36%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.18% | ||
| ROE | -0.35% | ||
| ROIC | 2.86% |
ROA(3y)-1.71%
ROA(5y)1.06%
ROE(3y)-3.65%
ROE(5y)0.24%
ROIC(3y)1.36%
ROIC(5y)3.41%
1.3 Margins
- ICUI has a Operating Margin of 5.63%. This is in the better half of the industry: ICUI outperforms 70.43% of its industry peers.
- In the last couple of years the Operating Margin of ICUI has declined.
- ICUI has a Gross Margin of 36.47%. This is in the lower half of the industry: ICUI underperforms 71.51% of its industry peers.
- In the last couple of years the Gross Margin of ICUI has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.63% | ||
| PM (TTM) | N/A | ||
| GM | 36.47% |
OM growth 3Y-26.21%
OM growth 5Y-22.36%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.48%
GM growth 5Y-1.46%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ICUI is destroying value.
- Compared to 1 year ago, ICUI has more shares outstanding
- The number of shares outstanding for ICUI has been increased compared to 5 years ago.
- ICUI has a worse debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 2.26 indicates that ICUI is not a great score, but indicates only limited risk for bankruptcy at the moment.
- ICUI has a Altman-Z score of 2.26. This is in the better half of the industry: ICUI outperforms 64.52% of its industry peers.
- The Debt to FCF ratio of ICUI is 21.21, which is on the high side as it means it would take ICUI, 21.21 years of fcf income to pay off all of its debts.
- Looking at the Debt to FCF ratio, with a value of 21.21, ICUI is in the better half of the industry, outperforming 69.35% of the companies in the same industry.
- ICUI has a Debt/Equity ratio of 0.62. This is a neutral value indicating ICUI is somewhat dependend on debt financing.
- The Debt to Equity ratio of ICUI (0.62) is worse than 62.90% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.62 | ||
| Debt/FCF | 21.21 | ||
| Altman-Z | 2.26 |
ROIC/WACC0.29
WACC9.98%
2.3 Liquidity
- A Current Ratio of 2.45 indicates that ICUI has no problem at all paying its short term obligations.
- Looking at the Current ratio, with a value of 2.45, ICUI is in line with its industry, outperforming 51.08% of the companies in the same industry.
- ICUI has a Quick Ratio of 1.19. This is a normal value and indicates that ICUI is financially healthy and should not expect problems in meeting its short term obligations.
- ICUI has a Quick ratio of 1.19. This is in the lower half of the industry: ICUI underperforms 67.20% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.45 | ||
| Quick Ratio | 1.19 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 40.14% over the past year.
- The Earnings Per Share has been decreasing by -5.28% on average over the past years.
- The Revenue has decreased by -0.84% in the past year.
- Measured over the past years, ICUI shows a quite strong growth in Revenue. The Revenue has been growing by 13.47% on average per year.
EPS 1Y (TTM)40.14%
EPS 3Y-5.58%
EPS 5Y-5.28%
EPS Q2Q%27.67%
Revenue 1Y (TTM)-0.84%
Revenue growth 3Y21.86%
Revenue growth 5Y13.47%
Sales Q2Q%-9.48%
3.2 Future
- The Earnings Per Share is expected to grow by 14.56% on average over the next years. This is quite good.
- The Revenue is expected to grow by 2.95% on average over the next years.
EPS Next Y23.92%
EPS Next 2Y14.84%
EPS Next 3Y14.98%
EPS Next 5Y14.56%
Revenue Next Year-4.9%
Revenue Next 2Y-3.64%
Revenue Next 3Y-1.17%
Revenue Next 5Y2.95%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 18.84, the valuation of ICUI can be described as rather expensive.
- ICUI's Price/Earnings ratio is rather cheap when compared to the industry. ICUI is cheaper than 83.33% of the companies in the same industry.
- When comparing the Price/Earnings ratio of ICUI to the average of the S&P500 Index (28.41), we can say ICUI is valued slightly cheaper.
- Based on the Price/Forward Earnings ratio of 18.28, the valuation of ICUI can be described as rather expensive.
- Based on the Price/Forward Earnings ratio, ICUI is valued cheaply inside the industry as 83.87% of the companies are valued more expensively.
- The average S&P500 Price/Forward Earnings ratio is at 25.64. ICUI is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.84 | ||
| Fwd PE | 18.28 |
4.2 Price Multiples
- 82.80% of the companies in the same industry are more expensive than ICUI, based on the Enterprise Value to EBITDA ratio.
- Based on the Price/Free Cash Flow ratio, ICUI is valued a bit cheaper than the industry average as 71.51% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 59.48 | ||
| EV/EBITDA | 14.27 |
4.3 Compensation for Growth
- ICUI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- A more expensive valuation may be justified as ICUI's earnings are expected to grow with 14.98% in the coming years.
PEG (NY)0.79
PEG (5Y)N/A
EPS Next 2Y14.84%
EPS Next 3Y14.98%
5. Dividend
5.1 Amount
- ICUI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:ICUI (2/3/2026, 1:23:26 PM)
149.93
-1.52 (-1%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)02-25 2026-02-25/amc
Inst Owners118.03%
Inst Owner Change-2.33%
Ins Owners0.96%
Ins Owner Change-1.93%
Market Cap3.70B
Revenue(TTM)2.32B
Net Income(TTM)-7.36M
Analysts83.33
Price Target185.03 (23.41%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)38.05%
Min EPS beat(2)37.25%
Max EPS beat(2)38.85%
EPS beat(4)4
Avg EPS beat(4)36.86%
Min EPS beat(4)31.74%
Max EPS beat(4)39.58%
EPS beat(8)8
Avg EPS beat(8)33.65%
EPS beat(12)12
Avg EPS beat(12)26.3%
EPS beat(16)15
Avg EPS beat(16)20.15%
Revenue beat(2)1
Avg Revenue beat(2)0.33%
Min Revenue beat(2)-1.77%
Max Revenue beat(2)2.43%
Revenue beat(4)3
Avg Revenue beat(4)1.47%
Min Revenue beat(4)-1.77%
Max Revenue beat(4)3.09%
Revenue beat(8)6
Avg Revenue beat(8)0.95%
Revenue beat(12)6
Avg Revenue beat(12)-0.92%
Revenue beat(16)8
Avg Revenue beat(16)-0.53%
PT rev (1m)0%
PT rev (3m)4.13%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.97%
EPS NY rev (1m)0%
EPS NY rev (3m)8.13%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.27%
Revenue NY rev (1m)-0.31%
Revenue NY rev (3m)0.67%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.84 | ||
| Fwd PE | 18.28 | ||
| P/S | 1.6 | ||
| P/FCF | 59.48 | ||
| P/OCF | 23.22 | ||
| P/B | 1.74 | ||
| P/tB | N/A | ||
| EV/EBITDA | 14.27 |
EPS(TTM)7.96
EY5.31%
EPS(NY)8.2
Fwd EY5.47%
FCF(TTM)2.52
FCFY1.68%
OCF(TTM)6.46
OCFY4.31%
SpS93.98
BVpS86.16
TBVpS-1.47
PEG (NY)0.79
PEG (5Y)N/A
Graham Number124.22
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.18% | ||
| ROE | -0.35% | ||
| ROCE | 3.62% | ||
| ROIC | 2.86% | ||
| ROICexc | 3.12% | ||
| ROICexgc | 9.01% | ||
| OM | 5.63% | ||
| PM (TTM) | N/A | ||
| GM | 36.47% | ||
| FCFM | 2.68% |
ROA(3y)-1.71%
ROA(5y)1.06%
ROE(3y)-3.65%
ROE(5y)0.24%
ROIC(3y)1.36%
ROIC(5y)3.41%
ROICexc(3y)1.47%
ROICexc(5y)4.61%
ROICexgc(3y)4.17%
ROICexgc(5y)7.18%
ROCE(3y)1.72%
ROCE(5y)4.32%
ROICexgc growth 3Y-18.09%
ROICexgc growth 5Y-16.18%
ROICexc growth 3Y-37.66%
ROICexc growth 5Y-28.8%
OM growth 3Y-26.21%
OM growth 5Y-22.36%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.48%
GM growth 5Y-1.46%
F-Score7
Asset Turnover0.57
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.62 | ||
| Debt/FCF | 21.21 | ||
| Debt/EBITDA | 3.95 | ||
| Cap/Depr | 47.91% | ||
| Cap/Sales | 4.19% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 47.79% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.45 | ||
| Quick Ratio | 1.19 | ||
| Altman-Z | 2.26 |
F-Score7
WACC9.98%
ROIC/WACC0.29
Cap/Depr(3y)41.42%
Cap/Depr(5y)66.41%
Cap/Sales(3y)4.1%
Cap/Sales(5y)5.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)40.14%
EPS 3Y-5.58%
EPS 5Y-5.28%
EPS Q2Q%27.67%
EPS Next Y23.92%
EPS Next 2Y14.84%
EPS Next 3Y14.98%
EPS Next 5Y14.56%
Revenue 1Y (TTM)-0.84%
Revenue growth 3Y21.86%
Revenue growth 5Y13.47%
Sales Q2Q%-9.48%
Revenue Next Year-4.9%
Revenue Next 2Y-3.64%
Revenue Next 3Y-1.17%
Revenue Next 5Y2.95%
EBIT growth 1Y142.55%
EBIT growth 3Y-10.08%
EBIT growth 5Y-11.9%
EBIT Next Year43.36%
EBIT Next 3Y18.75%
EBIT Next 5Y17.88%
FCF growth 1Y597.89%
FCF growth 3Y-15.14%
FCF growth 5YN/A
OCF growth 1Y117.81%
OCF growth 3Y-8.63%
OCF growth 5Y14.9%
ICU MEDICAL INC / ICUI FAQ
What is the ChartMill fundamental rating of ICU MEDICAL INC (ICUI) stock?
ChartMill assigns a fundamental rating of 4 / 10 to ICUI.
Can you provide the valuation status for ICU MEDICAL INC?
ChartMill assigns a valuation rating of 6 / 10 to ICU MEDICAL INC (ICUI). This can be considered as Fairly Valued.
What is the profitability of ICUI stock?
ICU MEDICAL INC (ICUI) has a profitability rating of 4 / 10.
Can you provide the financial health for ICUI stock?
The financial health rating of ICU MEDICAL INC (ICUI) is 4 / 10.
What is the expected EPS growth for ICU MEDICAL INC (ICUI) stock?
The Earnings per Share (EPS) of ICU MEDICAL INC (ICUI) is expected to grow by 23.92% in the next year.